Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
98 | 3 | STATINS//JOURNAL OF LIPID RESEARCH//LIPOPROTEINS | 77402 |
2991 | 2 | STATINS//HEMISPHERIC CHEMICAL DOMINANCE//MEMBRANE NA K ATPASE | 2810 |
7843 | 1 | STATINS//LOVASTATIN//SIMVASTATIN | 1346 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | STATINS | authKW | 507908 | 30% | 5% | 408 |
2 | LOVASTATIN | authKW | 235852 | 7% | 11% | 93 |
3 | SIMVASTATIN | authKW | 118646 | 8% | 5% | 105 |
4 | HMG COA REDUCTASE INHIBITORS | authKW | 67607 | 4% | 5% | 55 |
5 | HYDROXYMETHYLGLUTARYL COA REDUCTASE INHIBITORS | authKW | 59906 | 2% | 10% | 26 |
6 | MEVALONATE PATHWAY | authKW | 52887 | 2% | 9% | 26 |
7 | BB BIOCYT | address | 52679 | 0% | 75% | 3 |
8 | PEDIAT PNEUMONOL ALLERG DIS HEMATOL | address | 52679 | 0% | 75% | 3 |
9 | HMG COA REDUCTASE | authKW | 48246 | 3% | 5% | 39 |
10 | 3 HYDROXY 3 METHYL GLUTARYL COENZYME A HMG COA REDUCTASE INHIBITORS | authKW | 46827 | 0% | 100% | 2 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 12972 | 51% | 0% | 685 |
2 | Urology & Nephrology | 602 | 7% | 0% | 92 |
3 | Gastroenterology & Hepatology | 359 | 6% | 0% | 75 |
4 | Pharmacology & Pharmacy | 284 | 11% | 0% | 147 |
5 | Cell Biology | 205 | 8% | 0% | 112 |
6 | Hematology | 203 | 5% | 0% | 61 |
7 | Public, Environmental & Occupational Health | 159 | 6% | 0% | 79 |
8 | Medicine, Research & Experimental | 100 | 4% | 0% | 60 |
9 | Biochemistry & Molecular Biology | 36 | 9% | 0% | 125 |
10 | Endocrinology & Metabolism | 25 | 3% | 0% | 40 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | BB BIOCYT | 52679 | 0% | 75% | 3 |
2 | PEDIAT PNEUMONOL ALLERG DIS HEMATOL | 52679 | 0% | 75% | 3 |
3 | BOSTON MAV 151 | 46827 | 0% | 100% | 2 |
4 | KAISER RIVERSIDE MED | 46827 | 0% | 100% | 2 |
5 | ST MED | 46827 | 0% | 100% | 2 |
6 | TAMPERE PANCREAS | 31213 | 0% | 33% | 4 |
7 | ALLERGY HLTH SCI | 23414 | 0% | 100% | 1 |
8 | ANALYT METAB CORE | 23414 | 0% | 100% | 1 |
9 | ANGIOGENESE RECH TRANSLAT INSERM EQUIPE ELLI | 23414 | 0% | 100% | 1 |
10 | ANGIOL WUPPERTAL | 23414 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER PREVENTION RESEARCH | 2635 | 1% | 1% | 12 |
2 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2444 | 2% | 0% | 26 |
3 | PROSTATE CANCER AND PROSTATIC DISEASES | 2049 | 1% | 1% | 10 |
4 | CANCER CAUSES & CONTROL | 1995 | 1% | 1% | 17 |
5 | INTERNATIONAL JOURNAL OF CANCER | 1345 | 3% | 0% | 35 |
6 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1342 | 2% | 0% | 24 |
7 | PROSTATE | 1110 | 1% | 0% | 15 |
8 | EXPERT OPINION ON DRUG SAFETY | 1013 | 1% | 1% | 7 |
9 | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 926 | 1% | 0% | 9 |
10 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 924 | 1% | 0% | 11 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |